CLEC5A (MDL-1) is a novel PU.1 transcriptional target during myeloid differentiation

Molecular Immunology

Volumn 48, Issue 4, 2011, Pages 714-719

  Batliner, Jasmin ^a   Mancarelli, Maria Michela ^b   Jenal, Mathias ^a   Reddy, Venkateshwar A ^c   Fey, Martin F ^a,d   Torbett, Bruce E ^b   Tschan, Mario P ^a,d  

^a UNIVERSITY OF BERN   (Switzerland)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c Novartis Institute of Functional Genomics   (United States)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

CLEC5A; Innate immunity; Myeloid differentiation; PU.1

Indexed keywords

C TYPE LECTIN DOMAIN FAMILY 5 MEMBER A; CELL SURFACE RECEPTOR; LECTIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GRANULOCYTE; HUMAN; HUMAN CELL; IN VIVO STUDY; MACROPHAGE; MONOCYTE; NULL CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, LEUKEMIC; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; LECTINS, C-TYPE; LEUKEMIA, MYELOID, ACUTE; LEUKEMIA, PROMYELOCYTIC, ACUTE; MACROPHAGES; MICE; MOLECULAR SEQUENCE DATA; MONOCYTES; MYELOID CELLS; NEUTROPHILS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; RECEPTORS, CELL SURFACE; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 78650594375     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.10.016     Document Type: Article

References (21)

1. Andrews N.C., Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian-cells. Nucleic Acids Res. 1991, 19:2499-12499.
2. Aoki N., Zganiacz A., Margetts P., Xing Z. Differential regulation of DAP12 and molecules associated with DAP12 during host responses to mycobacterial infection. Infect. Immun. 2004, 72:2477-2483.
3. Aoki N., Kimura Y., Kimura S., Nagato T., Azumi M., Kobayashi H., Sato K., Tateno M. Expression and functional role of MDL-1 (CLEC5A) in mouse myeloid lineage cells. J. Leukoc. Biol. 2009, 85:508-517.
4. Bakker A.B., Baker E., Sutherland G.R., Phillips J.H., Lanier L.L. Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:9792-9796.
5. Campbell K.S., Colonna M. DAP12: a key accessory protein for relaying signals by natural killer cell receptors. Int. J. Biochem. Cell Biol. 1999, 31:631-636.
6. Chen S.T., Lin Y.L., Huang M.T., Wu M.F., Cheng S.C., Lei H.Y., Lee C.K., Chiou T.W., Wong C.H., Hsieh S.L. CLEC5A is critical for dengue-virus-induced lethal disease. Nature 2008, 453:672-676.
7. Gingras M.C., Lapillonne H., Margolin J.F. TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development. Mol. Immunol. 2002, 38:817-824.
8. Henkel G.W., McKercher S.R., Maki R.A. Identification of three genes up-regulated in PU.1 rescued monocytic precursor cells. Int. Immunol. 2002, 14:723-732.
9. Inui M., Kikuchi Y., Aoki N., Endo S., Maeda T., Sugahara-Tobinai A., Fujimura S., Nakamura A., Kumanogoh A., Colonna M., Takai T. Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4816-4821.
10. Jenal M., Batliner J., Reddy V.A., Haferlach T., Tobler A., Fey M.F., Torbett B.E., Tschan M.P. The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1. Leukemia 2010, 24:1073-1076.
11. Lanier L.L., Bakker A.B. The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function. Immunol. Today 2000, 21:611-614.
12. Lanier L.L., Corliss B.C., Wu J., Leong C., Phillips J.H. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 1998, 391:703-707.
13. Mueller B.U., Pabst T., Fos J., Petkovic V., Fey M.F., Asou N., Buergi U., Tenen D.G. ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression. Blood 2006, 107:3330-3338.
14. Radziwill G., Erdmann R.A., Margelisch U., Moelling K. The Bcr kinase downregulates ras signaling by phosphorylating AF-6 and binding to its PDZ domain. Mol. Cell. Biol. 2003, 23:4663-4672.
15. Tessarz A.S., Cerwenka A. The TREM-1/DAP12 pathway. Immunol. Lett. 2008, 116:111-116.
16. Tschan M.P., Vonlanthen S., Cajot J.F., Peters U.R., Oppliger E., Betticher D.C., Yarbrough W.G., Fey M.F., Tobler A. Different p16INK4a and p14ARF expression patterns in acute myeloid leukaemia and normal blood leukocytes. Leuk. Lymphoma 2001, 42:1077-1087.
17. Tschan M.P., Fischer K.M., Fung V.S., Pirnia F., Borner M.M., Fey M.F., Tobler A., Torbett B.E. Alternative splicing of the human cyclin D-binding Myb-like protein (hDMP1) yields a truncated protein isoform that alters macrophage differentiation patterns. J. Biol. Chem. 2003, 278:42750-42760.
18. Tschan M.P., Reddy V.A., Ress A., Arvidsson G., Fey M.F., Torbett B.E. PU.1 binding to the p53 family of tumor suppressors impairs their transcriptional activity. Oncogene 2008, 27:3489-3493.
19. Weigelt K., Ernst W., Walczak Y., Ebert S., Loenhardt T., Klug M., Rehli M., Weber B.H., Langmann T. Dap12 expression in activated microglia from retinoschisin-deficient retina and its PU.1-dependent promoter regulation. J. Leukoc. Biol. 2007, 82:1564-1574.
20. Weigelt K., Moehle C., Stempfl T., Weber B., Langmann T. An integrated workflow for analysis of ChIP-chip data. Biotechniques 2008, 45:131-132. 134, 136 passim.
21. Weinbert M.S., Villeneuve L.M., Ehsani A., Amarzguioui M., Aagaard L., Chen Z.-X., Riggs A.D., Rossi J.J., Morris K.V. The antisense strand of small interfering RNAs directs histone methylation and transcriptional gene silencing in human cells. RNA 2006, 12:256-262.